Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens

The RV144 prime-boost regimen demonstrated efficacy against HIV acquisition while VAX003 and VAX004 did not. Although these trials differed by risk groups, immunization regimens, and immunogens, antibody responses may have contributed to the differences observed in vaccine efficacy. We assessed HIV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Karnasuta, Chitraporn, Akapirat, Siriwat, Madnote, Sirinan, Savadsuk, Hathairat, Puangkaew, Jiraporn, Rittiroongrad, Surawach, Rerks-Ngarm, Supachai, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Kaewkungwal, Jaranit, Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., de Souza, Mark S., Michael, Nelson L., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J., Karasavvas, Nicos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439458/
https://www.ncbi.nlm.nih.gov/pubmed/28006952
http://dx.doi.org/10.1089/aid.2016.0204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439458/
https://www.ncbi.nlm.nih.gov/pubmed/28006952
http://dx.doi.org/10.1089/aid.2016.0204

Ejemplares similares